Ahmed Tharwat

Alfasigma

Alfasigma is a major pharmaceutical group created in 2015 by the aggregation of two historic Italian companies, Alfa Wassermann and Sigma-Tau. In times of rapid change and global competition, pharmaceutical companies have to be big enough to take on the challenges of the market and invest the necessary resources in research, development and innovation. For this reason, the two companies decided to pool their assets in terms of workforce, products and skills, and thereby lay the foundations for further growth. Alfasigma is among the top five players in the pharmaceutical industry in Italy, both in terms of prescription and OTC products, and is well established internationally. It is a sound group, in step with the times, with a successful past behind it and great future ahead. Alfasigma works to create lasting, shared values: For people by improving their health and quality of life and finding solutions to treat a population which is becoming increasingly elderly, thanks precisely to scientific progress; For the company and its staff by striving to create wealth, nurturing ideas and projects, and capitalizing on the enthusiasm of its employees; For society by endeavouring to provide security, working sustainably with a view to the long term, and providing far-reaching solutions for healthcare needs, which are becoming increasingly global; For future generations by providing innovation and responding to the needs of a changing society. Alfasigma strives to be a strong, healthy company in a strong, healthy world